OPTOCIRCUI

Opto Circuits (India) Limited has informed the Exchange that the Company, for the purpose of cost effectiveness and operational efficiency, has taken restructuring initiative and transferred the investments of three of its US Subsidiaries, Cardiac Science Corporation, Criticare Systems Inc., and Unetixs Vascular Inc., into Opto Cardiac Care Limited, a Wholly Owned Subsidiary of Opto Circuits (India) Limited. Further, the Company has also transferred the investments of its subsidiaries, Eurocor Gmbh, and N.S.Remedies Private Limited, into Opto Eurocor Healthcare Limited, a Wholly Owned Subsidia

Opto Circuits (India) Limited has informed the Exchange that Opto Circuits (India) Ltd.'s subsidiary Cardiac Science Corporation has received regulatory clearance from the Japan Ministry of Health, Labor, and Welfare to market its Powerheart G3 Automated External Defibrillators (AED) in Japan.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 19, 2011, titled "Eurocor presented 12 months outcome of Spanish Registry at EuroPCR in Paris".

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors at its Meeting held on May 17, 2011 have recommended a Dividend of 45% (Rs. 4.50 per Equity share face value of Rs. 10/- each ) for the year 2010-11, subject to the approval of the Shareholders at the Annual General Meeting.

Opto Circuits (India) Limited has submitted to the Exchange the Standalone Financial Results for the period ended March 31,2011.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 60320.27 lacs for year ending on 31-MAR-2011 against Rs. 47149.67 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 24412.55 lacs for the year ending on 31-MAR-2011 against Rs. 14687.82 lacs for the year ending on 31-MAR-2010.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the year ended on 31-MAR-2011 as follows: Net Sales of Rs. 158556.31 lacs for year ending on 31-MAR-2011 against Rs. 107758.26 lacs for the year ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 36720.59 lacs for the year ending on 31-MAR-2011 against Rs. 26007.36 lacs for the year ending on 31-MAR-2010.

Opto Circuits (India) Limited has submitted to the Exchange the Consolidated Financial Results for the period ended March 31,2011.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated April 27, 2011, titled "Opto Circuits' US subsidiary Cardiac Science wins large European AED contract."

Opto Circuits (India) Limited has informed the Exchange that the Company will publish the Audited Results of the Company for the accounting year ended March 31, 2011 within the prescribed period. Therefore, the quarterly result for the last quarter ended March 31, 2011 will not be published within the stipulated period from the close of the quarter.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated March 14, 2011, titled "Opto Circuits subsidiary Eurocor's partner Micell Technologies enrolls first patient in randomized trial for MiStent DES, a novel sirolimus-eluting stent system".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated March 03, 2011, titled "Opto Circuits' subsidiary Eurocor announces Study results of Valentines Trial I".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 22, 2011, titled "Opto Circuits' subsidiary, Eurocor, launches MAGICAL (R) in India First ever combinational device angioplasty carried out in India".

Opto Circuits (India) Limited has informed the Exchange that OPTO CARDIAC CARE LIMITED Bangalore has become wholly owned subsidiary of the company, after complying with all the legal formalities.

Opto Circuits (India) Limited has informed the Exchange that Company's wholly owned subsidiary i.e. Altron Industries Pvt Limited's name has changed to OPTO EUROCOR HEALTHCARE PVT LTD., The company has complied with all legal and statutory formalities.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 15, 2011, titled "Opto Circuits' subsidiary Eurocor GmbH launches international multi-center registry - Valentines Trail II".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 10, 2011, titled "U.S. Postal Inspection Service Awards AED Contract to Cardiac Science".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 08, 2011, titled "Eurocor Steps Up Research Activities".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated February 02, 2011, titled "Opto Circuits' US subsidiary Cardiac Science awarded Global AED Contract by Tyco Division; Cardiac Science AEDs will protect Tyco facilities worldwide".

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors of the company on January 27, 2011 converted 31,25,000 share warrants and allotted 31,25,000 equity shares. The details of allotment are as follows. Name of the Allottee : Mr. Vinod Ramnani, No of Shares allotted: 10,00,000, Name of the Allottee : Mrs Usha Ramnani, No of Shares allotted: 10,00,000, Name of the Allottee : Mr. Gautham G Gumnani, No of Shares allotted: 11,25,000

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 24, 2011, titled "Opto Circuits' US subsidiary Cardiac Science Awarded US Military Certification".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 21, 2011, titled "Opto Circuits subsidiary ready to launch its solutions for treating peripheral arterial disease (PAD) in Germany".

Opto Circuits (India) Limited has submitted to the Exchange the Standalone Financial Results for the period ended December 31,2010.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 31-DEC-2010 as follows: Net Sales of Rs. 41765.95 lacs for quarter ending on 31-DEC-2010 against Rs. 33137.8 lacs for the quarter ending on 30-SEP-2010. Net Profit / (Loss) of Rs. 9567.54 lacs for the quarter ending on 31-DEC-2010 against Rs. 7737.52 lacs for the quarter ending on 30-SEP-2010.

Opto Circuits (India) Limited has submitted to the Exchange the Consolidated Financial Results for the period ended December 31,2010.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated January 07, 2011, titled "Opto Circuits' US subsidiary Cardiac Science extends device connectivity to Allscripts Professional (TM) Electronic Health Record".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 10, 2010, titled "Opto Circuits' new subsidiary Cardiac Science Introduces the Next Generation of Burdick ECG Devices".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 06, 2010, titled "Opto Circuits' subsidiary enters Indian market with PTCA combination device - Company gets DCGI registration for "MAGICAL(TM)".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated December 06, 2010, titled "Opto Circuits Successfully Completes Acquisition of Cardiac Science".

Opto Circuits (India) Limited has informed the Exchange that "the company has successfully acquired 76% of outstanding common stock of Cardiac Science Corporation US (Nasdaq:CSCX). The company plans to exercise its top-up option under the terms of the merger agreement. The merger is expected to occur in the next few days. Following the merger, Cardiac Science will become a wholly-owned subsidiary of Opto Circuits (India) Limited."

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 22, 2010, titled "Opto Circuits' subsidiary, Eurocor, launches latest drug-eluting balloon technology FREEWAY, specifically designed for peripheral interventions".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated November 18, 2010, titled "Criticare Systems Releases Next Generation CO2/N2O Gas Bench."

Opto Circuits (India) Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended September 30,2010.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 14320.64 lacs for quarter ending on 30-SEP-2010 against Rs. 12749.42 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 5112.03 lacs for the quarter ending on 30-SEP-2010 against Rs. 5695.43 lacs for the quarter ending on 30-JUN-2010.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2010 as follows: Net Sales of Rs. 33137.8 lacs for quarter ending on 30-SEP-2010 against Rs. 29198 lacs for the quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 7737.52 lacs for the quarter ending on 30-SEP-2010 against Rs. 8309.78 lacs for the quarter ending on 30-JUN-2010.

Opto Circuits (India) Limited has informed the Exchange vide its letter dated October 22, 2010 regarding a press release dated October 21, 2010 titled "Opto Circuits sharpens focus on Emerging Markets".

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated October 19, 2010 , titled "Opto Circuits to acquire Cardiac Science".

Opto Circuits (India) Limited has informed the Exchange that Rating Committee of ICRA has upgraded the Company's long-term rating for the Line of Credit ( LOC) from LA+ (pronounced LA Plus) to LAA (pronounced as double A). The Out look on the long-term rating is stable. The Rating Committee of ICRA has also retained the short-term rating for the LOC at A1+ (pronounced A one plus).

Opto Circuits (India) Limited has informed the Exchange regarding the press release dated September 27, 2010 titled "Opto Circuits' subsidiary Eurocor's next-gen DEB products gain wide interest amongst United States Interventional cardiologists".

Opto Circuits (India) Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company will be closed from September 23, 2010 to September 28, 2010 (both days inclusive) for the purpose of payment of dividend. The Annual General Meeting of the Members of the Company will be held on September 28, 2010.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated September 06, 2010, titled "Opto Circuits' US subsidiary-Criticare Systems Inc.'s new modular patient monitor eVision 9100 recieves US FDA 510 (K) Clearance".

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 12749.42 lacs for quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 5695.43 lacs for the quarter ending on 30-JUN-2010.

Opto Circuits (India) Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-JUN-2010 as follows: Net Sales of Rs. 29198 lacs for quarter ending on 30-JUN-2010. Net Profit / (Loss) of Rs. 8309.78 lacs for the quarter ending on 30-JUN-2010.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated July 27, 2010, titled "Opto Circuits India acquires Unetixs Vascular, Inc."

Opto Circuits (India) Limited has informed the Exchange that Mr. Srinatha A. N. has been appointed as Company Secretary and Compliance Officer of the Company in place Mr. Vijayendra.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated July 07, 2010, titled "Opto Circuits' subsidiary, EuroCor, successfully showcases Drug Eluting Balloon to Asian cardiologists".

Opto Circuits (India) Limited has informed the Exchange that 15,00,000 convertible share warrants were allotted to Mr. Gautham Gumnani on April 9, 2010, on receipt of FIPB approval No 31/ (2010)/166(2009) dated April 6, 2010, which is within 15 days from the FIPB approval. The Company has converted 3,75,000 of these convertible warrants into 3,75,000 equity shares and allotted the same to Mr. Gautham G. Gumnani on June 14, 2010.

Opto Circuits (India) Limited has informed the Exchange regarding a press release dated May 28, 2010, titled "Opto Circuits (I) Ltd. subsidiary EuroCor GmbH presents very convincing clinical results from the DIOR� DEBUIT Trial".

Opto Circuits (India) Limited has informed the Exchange that the Board of Directors at its Meeting held on May 24, 2010 have recommended a Dividend of Rs. 4/- per Equity share (face value of Rs. 10/- each ) for the year 2009-10, subject to the approval of the Shareholders in the General Meeting.

Opto Circuits (India) Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2010 as follows: Net Sales of Rs. 13562 lacs for quarter ending on 31-MAR-2010. Net Profit / (Loss) of Rs. 4385.88 lacs for the quarter ending on 31-MAR-2010.